Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Trouble neurologique fonctionnel associé à la vaccination contre le SRAS-CoV-2Canadian Medical Association journal (CMAJ), 2022-11, Vol.194 (45), p.E1551-E1553 [Peer Reviewed Journal]COPYRIGHT 2022 CMA Impact Inc. ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.220039-fFull text available |
2 |
Material Type: Article
|
![]() |
Faciliter l'acces aux donnees administratives sur la vaccination anti-SRAS-CoV-2 aux fins de la rechercheCanadian Medical Association journal (CMAJ), 2022-08, Vol.194 (33), p.E1147 [Peer Reviewed Journal]COPYRIGHT 2022 CMA Impact Inc. ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.211712-fFull text available |
3 |
Material Type: Article
|
![]() |
Trouble neurologique fonctionnel associe a la vaccination contre le SRAS-CoV-2Canadian Medical Association journal (CMAJ), 2022-11, Vol.194 (45), p.E1551 [Peer Reviewed Journal]COPYRIGHT 2022 CMA Impact Inc. ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.220039-fFull text available |
4 |
Material Type: Article
|
![]() |
La vaccination contre le SRAS-CoV-2 devrait etre obligatoire pour exercer la medecine au CanadaCanadian Medical Association journal (CMAJ), 2022-01, Vol.194 (3), p.E110 [Peer Reviewed Journal]COPYRIGHT 2022 CMA Joule Inc. ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.211839-fFull text available |
5 |
Material Type: Article
|
![]() |
COVID-19 Vaccination Hesitancy in the United States: A Rapid National AssessmentJournal of community health, 2021-04, Vol.46 (2), p.270-277 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 ;The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021. ;ISSN: 0094-5145 ;EISSN: 1573-3610 ;DOI: 10.1007/s10900-020-00958-x ;PMID: 33389421Full text available |
6 |
Material Type: Article
|
![]() |
Vaccination contre le SRAS-CoV-2 durant la grossesseCanadian Medical Association journal (CMAJ), 2024-01, Vol.196 (2), p.E59-E60 [Peer Reviewed Journal]COPYRIGHT 2024 CMA Impact Inc. ;2024 CMA Impact Inc. or its licensors 2024 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.221556-f ;PMID: 38253371Full text available |
7 |
Material Type: Article
|
![]() |
Mandate vaccination with careNature (London), 2019-07, Vol.571 (7766), p.469-472 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Jul 25, 2019 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-019-02232-0 ;PMID: 31332351Full text available |
8 |
Material Type: Article
|
![]() |
NVX-CoV2373, un vaccin à sous-unités protéiques contre l’infection au SRAS-CoV-2Canadian Medical Association journal (CMAJ), 2022-11, Vol.194 (45), p.E1554-E1555 [Peer Reviewed Journal]COPYRIGHT 2022 CMA Impact Inc. ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.220688-fFull text available |
9 |
Material Type: Article
|
![]() |
Faciliter l’accès aux données administratives sur la vaccination anti-SRAS-CoV-2 aux fins de la rechercheCanadian Medical Association journal (CMAJ), 2022-08, Vol.194 (33), p.E1147-E1152 [Peer Reviewed Journal]COPYRIGHT 2022 CMA Impact Inc. ;2022 CMA Impact Inc. or its licensors 2022 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.211712-fFull text available |
10 |
Material Type: Article
|
![]() |
La vaccination contre le SRAS-CoV-2 devrait être obligatoire pour exercer la médecine au CanadaCanadian Medical Association journal (CMAJ), 2022-01, Vol.194 (3), p.E110-E111 [Peer Reviewed Journal]COPYRIGHT 2022 CMA Joule Inc. ;2022 CMA Impact Inc. or its licensors 2022 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.211839-f ;PMID: 35074843Full text available |
11 |
Material Type: Article
|
![]() |
Atteinte et maintien de l’immunité collective contre le SRAS-CoV-2Canadian Medical Association journal (CMAJ), 2021-08, Vol.193 (32), p.E1279-E1280 [Peer Reviewed Journal]COPYRIGHT 2021 CMA Joule Inc. ;2021 CMA Joule Inc. or its licensors 2021 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.210892-f ;PMID: 34400490Full text available |
12 |
Material Type: Article
|
![]() |
L'experimentation medicale et les causes de la reticence a la vaccination contre la COVID-19 chez les peuples autochtones du CanadaCanadian Medical Association journal (CMAJ), 2021-06, Vol.193 (23), p.E892 [Peer Reviewed Journal]COPYRIGHT 2021 CMA Joule Inc. ;ISSN: 0820-3946 ;EISSN: 1488-2329Full text available |
13 |
Material Type: Article
|
![]() |
Etablir les priorites de la vaccination contre la COVID-19 en fonction de la prevalence des facteurs de risque chez les adultes au CanadaCanadian Medical Association journal (CMAJ), 2021-05, Vol.193 (22), p.E823 [Peer Reviewed Journal]COPYRIGHT 2021 CMA Joule Inc. ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.210529-fFull text available |
14 |
Material Type: Article
|
![]() |
Factors Associated with Willingness to be Vaccinated Against COVID-19 in a Large Convenience SampleJournal of community health, 2021-10, Vol.46 (5), p.1013-1019 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 ;2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021. ;ISSN: 0094-5145 ;EISSN: 1573-3610 ;DOI: 10.1007/s10900-021-00987-0 ;PMID: 33835369Full text available |
15 |
Material Type: Article
|
![]() |
Behavioural nudges increase COVID-19 vaccinationsNature (London), 2021-09, Vol.597 (7876), p.404-409 [Peer Reviewed Journal]2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Sep 16, 2021 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03843-2 ;PMID: 34340242Full text available |
16 |
Material Type: Article
|
![]() |
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity dataThe Lancet (British edition), 2021-05, Vol.397 (10289), p.2043-2046 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01115-6 ;PMID: 33991480Full text available |
17 |
Material Type: Article
|
![]() |
COVID-19 in Europe: new challenges for addressing vaccine hesitancyThe Lancet (British edition), 2022-02, Vol.399 (10326), p.699-701 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00150-7 ;PMID: 35123665Full text available |
18 |
Material Type: Article
|
![]() |
Vaccination contre la rougeoleCanadian Medical Association journal (CMAJ), 2024-05, Vol.196 (20), p.E709 [Peer Reviewed Journal]COPYRIGHT 2024 CMA Impact Inc. ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.240371-fFull text available |
19 |
Material Type: Article
|
![]() |
The case for mandatory vaccinationNature (London), 2019-11, Vol.575 (7784), p.S58-S60 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-019-03642-w ;PMID: 31776503Full text available |
20 |
Material Type: Article
|
![]() |
MeaslesThe Lancet (British edition), 2022-02, Vol.399 (10325), p.678-690 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02004-3 ;PMID: 35093206Full text available |